Hypertension medication Flashcards
Anti-HTN medications - RAAS inhibition
- Angiotensin Converting Enzyme Inhibitors (ACEIs)
- Angiotensin receptor blockers (ARBs)
- Diuretics (Loop diuretics, Thiazide-type diuretics, Potassium-sparing diuretics, - - —- Potassium-sparing/selective aldosterone blocker)
- Direct Renin Inhibitor (DRI)
Anti-HTN Medications - Sympathetic NS
- Alpha-Blocker
- Beta-Blocker
- Calcium Channel Blockers: dihydropyridines and non-dihydropyridines
ACE inhibitors mechanism of action
inhibits angiotensin converting enzyme, interfering w/ conversion of angiotensin I to angiotensin II
Angiotensin-Receptor Blocker (ARB) Mechanism of action
selectively antagonizes angiotensin II AT1 receptors
Thiazide Diuretics Mechanism of action
Inhibits distal convoluted tubule sodium and chloride resorption
Potassium sparing diuretics mechanism of action
inhibits Na reabsorption at the distal convoluted tubule, decreasing water reabsorption and increasing K retention
Loop diuretics mechanism of action
inhibits loop of Henle and proximal and distal convoluted tubule sodium and chloride resorption
Beta-blockers, cardio selective - mechanism of action
Selectively antagonizes beta-1 adrenergic receptors
Beta-blockers, non-selective - mechanism of action
selectively antagonizes alpha-1 adrenergic receptors; antagonizes beta-1 and beta-2 adrenergic receptors (selective alpha and non-selective beta blocker)
Vasodilators mechanism of action
directly dilates peripheral vessels
Calcium channel blockers - DHP, mechanism of action
inhibits calcium ion influx into vascular smooth muscle and myocardium
Calcium Channel Blockers -NDP, mechanism of action
inhibits calcium ion influx into vascular smooth muscle and myocardium (class IV antiarrhythmic)
Alpha-2 agonists mechanism of action
stimulates alpha-2 adrenergic receptors (centrally-acting antihypertensive)
Alpha-1 blocker mechanism of action
antagonizes peripheral alpha-1 adrenergic receptors
Principles of anti-HTN management
- Measure - What you don’t measure you can’t improve
- Use guidelines, but personalize
- Educate, educate, educate
- Lifestyle always
- Follow-up, follow-up, follow-up
- “Normal” = 1 yr, recheck
- “On the radar” = consider 2 week recheck, 3 months follow-up
- “Started meds” = 1 month - why? Follow til therapeutic, then extend. Consider 3 months, then 1 year
- Meds are predicated on co-morbidities or desired side effects